Novo Nordisk (NVO), the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, expects at least some short-term impacts from President Donald Trump’s proposed tariffs.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Even your weight loss drugs aren't safe from tariffs )
Also on site :
- G42 a Mistral AI sa spájajú so zámerom budovať platformy a infraštruktúry umelej inteligencie novej generácie
- Companies turn to AI to navigate Trump tariff turbulence
- Your new sofa could be the first sign tariff inflation is hitting home